Jul 1, 2025 · The active ingredient in Wegovy is semaglutide. Here’s a breakdown of Wegovy’s other inactive ingredients and how it’s made.

Dec 7, 2025 · Wegovy package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.

Oct 25, 2024 · Wondering what's in Wegovy? Learn about the key ingredients in Wegovy and how they contribute to effective weight loss management and improved health.

WEGOVY is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated in combination with a reduced calorie diet and increased physical activity:

The following adverse reactions have been reported during post-approval use of semaglutide, the active ingredient of WEGOVY. Because these reactions are reported voluntarily from a population of …

Aug 31, 2025 · Wegovy is used alongside a low-calorie diet and exercise. It’s approved for adults and children aged 12 and older with obesity or weight-related health issues. Understanding its ingredients …

WEGOVY® is contraindicated in patients who are hypersensitive to this drug or to any ingredient in the formulation, including any non-medicinal ingredient, or component of the container.

Serious Warnings and Precautions Possible Risk of thyroid tumours, including cancer As part of drug testing, semaglutide, the active ingredient in WEGOVY® was given to rats and mice in long term …

Do not use Wegovy® if: you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple …

Wegovy ® (semaglutide) injection 1.7 mg or 2.4 mg is used with a reduced-calorie diet and increased physical activity to help children 12 years and older with obesity to lose weight and keep the weight …